ASTEX
Live / Registered — Registered and renewed (as of 21 Apr 2022)
What this means for you
Registered since 10 Jan 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Jan 2022).
Record
- Serial number
- 76086645
- Registration number
- 4081552
- Mark type
- Design + words
- Filed
- 11 Jul 2000
- Published for opposition
- 12 Apr 2011
- Registered
- 10 Jan 2012
- Next maintenance due
- 10 Jan 2022
- Attorney of record
- Carole E. Klinger
Goods and services
- Class 009 — Scientific and electric apparatus: [ Computer software for manipulation and presentation of data for use in relation to drug discovery; computer software for manipulation and presentation of data for use in relation to biotechnology research ]
- Class 042 — Scientific and technological services: Drug discovery services; biotechnology research
Owner
- ASTEX THERAPEUTICS LIMITED, CAMBRIDGE, GB
- ASTEX THERAPEUTICS LIMITED, CAMBRIDGE CB4 0QA, GB
- ASTEX THERAPEUTICS LIMITED, CAMBRIDGE CB4 0QA, GB
- Astex Technology Limited, London SW1Y 6 DN, GB
Prosecution history
- 22 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Nov 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 22 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Nov 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Nov 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Oct 2024 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 25 Sept 2024 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 22 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Feb 2024 — TEAS SECTION 7 REQUEST RECEIVED
- 21 Apr 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Apr 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 Apr 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Dec 2021 — TEAS SECTION 8 & 9 RECEIVED